Structures by: Harish Chinthal C. H.
Total: 36
1-(3,5-dinitrobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H18N4O6
IUCrData (2020) 5, 11 x201523
a=25.348(2)Å b=7.3059(5)Å c=19.3470(10)Å
α=90° β=94.190(6)° γ=90°
1-(4-Fluorobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H19FN2O2
Acta Crystallographica Section E (2021) 77, 1 5-13
a=7.3286(6)Å b=11.3388(7)Å c=20.3040(10)Å
α=90° β=90° γ=90°
1-(4-Iodobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H19IN2O2
Acta Crystallographica Section E (2021) 77, 1 5-13
a=10.9626(5)Å b=11.3258(6)Å c=14.8234(7)Å
α=90° β=104.520(5)° γ=90°
1-(4-Chlorobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H19ClN2O2
Acta Crystallographica Section E (2021) 77, 1 5-13
a=29.7690(10)Å b=11.3173(4)Å c=20.4028(8)Å
α=90° β=90° γ=90°
1-(2-Fluorobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H19FN2O2
Acta Crystallographica Section E (2021) 77, 1 5-13
a=7.4510(10)Å b=11.199(3)Å c=19.138(5)Å
α=90° β=99.59(2)° γ=90°
1-(4-Bromobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H19BrN2O2
Acta Crystallographica Section E (2021) 77, 1 5-13
a=15.0779(7)Å b=11.2868(6)Å c=20.5297(9)Å
α=90° β=90° γ=90°
1-(3-Iodobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H19IN2O2
Acta Crystallographica Section E (2021) 77, 1 5-13
a=7.4528(4)Å b=17.1306(9)Å c=27.9030(10)Å
α=90° β=90° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 4-chlorobenzoate
C11H17N2O,C7H4ClO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.4010(10)Å b=7.8880(10)Å c=15.410(3)Å
α=100.28(2)° β=94.400(10)° γ=94.140(10)°
4-(2-Methoxyphenyl)piperazin-1-ium 4-bromobenzoate
C11H17N2O,C7H4BrO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.4313(5)Å b=7.9163(5)Å c=15.5212(9)Å
α=101.565(5)° β=94.780(5)° γ=92.691(5)°
4-(2-Methoxyphenyl)piperazin-1-ium 4-iodobenzoate
C11H17N2O,C7H4IO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.1129(4)Å b=11.2722(7)Å c=12.5923(8)Å
α=69.852(5)° β=74.681(5)° γ=79.121(5)°
4-(2-Methoxyphenyl)piperazin-1-ium 2-fluorobenzoate
C11H17N2O,C7H4FO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=19.9400(10)Å b=10.2705(7)Å c=9.0148(7)Å
α=90° β=109.663(8)° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 2-chlorobenzoate
C11H17N2O,C7H4ClO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.9974(8)Å b=27.611(2)Å c=8.5972(9)Å
α=90° β=106.400(10)° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 2-bromobenzoate
C11H17N2O,C7H4BrO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=6.9824(2)Å b=13.2292(4)Å c=19.4903(7)Å
α=90° β=90° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 2-iodobenzoate
C11H17N2O,C7H4IO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.0101(4)Å b=13.3796(6)Å c=19.5524(6)Å
α=90° β=90° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 2-methylbenzoate
C11H17N2O,C8H7O2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.8260(10)Å b=10.320(2)Å c=12.055(3)Å
α=78.37(2)° β=78.27(2)° γ=73.83(2)°
4-(2-Methoxyphenyl)piperazin-1-ium 4-aminobenzoate
C11H17N2O,C7H6NO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=14.9220(10)Å b=7.6951(5)Å c=15.5600(10)Å
α=90° β=106.911(8)° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 4-nitrobenzoate
C11H17N2O,C7H4NO4
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.5174(5)Å b=7.9761(5)Å c=29.860(2)Å
α=90° β=97.322(6)° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 3,5-dinitrobenzoate dihydrate
C11H17N2O,C7H3N2O6,2(H2O)
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.8448(6)Å b=11.4635(9)Å c=12.0747(9)Å
α=94.406(7)° β=105.075(8)° γ=93.717(7)°
4-(2-Methoxyphenyl)piperazin-1-ium 2,4,6-trinitrophenolate
C11H17N2O,C6H2N3O7
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=9.4151(5)Å b=9.8721(5)Å c=10.9572(5)Å
α=77.524(4)° β=81.360(5)° γ=81.002(5)°
4-(2-Methoxyphenyl)piperazin-1-ium hydrogen fumarate
C11H17N2O,0.5(C4H3O4),C1.14H0.86O1.14,C0.86H0.64O0.86)
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.8546(4)Å b=8.9626(6)Å c=11.2056(8)Å
α=79.043(5)° β=87.715(5)° γ=85.840(5)°
4-(2-Methoxyphenyl)piperazin-1-ium hydrogen maleate
C11H17N2O,C4H3O4
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=11.1076(6)Å b=11.1164(6)Å c=13.7649(7)Å
α=80.353(5)° β=78.353(5)° γ=74.406(5)°
4-(2-Methoxyphenyl)piperazin-1-ium hydrogen (2<i>R</i>,3<i>R</i>)-tartrate 1.698-hydrate
C11H17N2O,C4H5O6,1.698(H2O)
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.4790(10)Å b=7.0650(10)Å c=17.788(3)Å
α=90° β=101.58(2)° γ=90°
4-(4-Fluorophenyl)piperazin-1-ium 2-bromobenzoate 0.353-hydrate
C10H14FN2,C7H4BrO2,0.353(H2O)
Acta Crystallographica Section E (2020) 76, 8 1179-1186
a=7.2584(8)Å b=9.3470(10)Å c=13.767(2)Å
α=101.140(10)° β=95.980(10)° γ=109.440(10)°
4-(4-Fluorophenyl)piperazin-1-ium 2-fluorobenzoate monohydrate
C10H14FN2,C7H4FO2,H2O
Acta Crystallographica Section E (2020) 76, 8 1179-1186
a=6.5873(5)Å b=7.6616(6)Å c=17.3399(9)Å
α=97.842(6)° β=90.378(6)° γ=95.540(6)°
4-(4-Fluorophenyl)piperazin-1-ium 2-iodobenzoate
C10H14FN2,C7H4IO2
Acta Crystallographica Section E (2020) 76, 8 1179-1186
a=9.8892(3)Å b=11.6831(7)Å c=16.4547(9)Å
α=106.776(5)° β=93.327(4)° γ=104.874(4)°
4-(4-Fluorophenyl)piperazin-1-ium 2,4,6-trinitrophenolate
C10H14FN2,C6H2N3O7
Acta Crystallographica Section E (2020) 76, 8 1179-1186
a=16.658(2)Å b=6.6734(6)Å c=17.553(3)Å
α=90° β=117.84(2)° γ=90°
4-(4-Fluorophenyl)piperazin-1-ium 3,5-dinitrobenzoate
C10H14FN2,C7H3N2O6
Acta Crystallographica Section E (2020) 76, 8 1179-1186
a=19.8710(10)Å b=7.3420(7)Å c=26.306(2)Å
α=90° β=94.540(8)° γ=90°
<i>N</i>-{[4-(3-phenyl-4-sydnonylideneamino)-5-sulfanylidene-1<i>H</i>-1,2,4-triazol-3-yl]methyl}benzamide ethanol monosolvate
C19H15N7O3S,C2H6O
Acta Crystallographica Section E (2020) 76, 7 1057-1061
a=8.6313(6)Å b=10.8378(9)Å c=13.3840(10)Å
α=66.645(8)° β=79.287(8)° γ=85.151(8)°
<i>N</i>-({4-[3-(4-Methylphenyl)-4-sydnonylideneamino]-5-sulfanylidene-1<i>H</i>-1,2,4-triazol-3-yl}methyl)benzamide ethanol monosolvate
C20H17N7O3S,C2H6O
Acta Crystallographica Section E (2020) 76, 7 1057-1061
a=8.5631(5)Å b=11.1242(8)Å c=13.5632(9)Å
α=70.244(6)° β=76.086(7)° γ=84.058(6)°
4-(4-Fluorophenyl)piperazin-1-ium 2-hydroxy-3,5-dinitrobenzoate
C10H14FN2,C7H3N2O7
Acta Crystallographica Section E (2020) 76, 6 841-847
a=10.6829(6)Å b=13.1701(6)Å c=13.5563(7)Å
α=90° β=108.970(5)° γ=90°
4-(4-Fluorophenyl)piperazin-1-ium hydrogen oxalate
C10H14FN2,C2HO4
Acta Crystallographica Section E (2020) 76, 6 841-847
a=17.0606(6)Å b=5.7820(2)Å c=12.5815(5)Å
α=90° β=102.761(4)° γ=90°
4-(4-Fluorophenyl)piperazin-1-ium hydrogen (2<i>R</i>,3<i>R</i>)-tartrate monohydrate
C10H14FN2,C4H5O6,H2O
Acta Crystallographica Section E (2020) 76, 6 841-847
a=7.0961(4)Å b=7.4967(4)Å c=30.757(2)Å
α=90° β=90° γ=90°
<i>N</i>-(4-Methoxyphenyl)piperazine
C11H16N2O
Acta Crystallographica Section E (2020) 76, 4 488-495
a=6.9683(7)Å b=7.9683(8)Å c=18.975(2)Å
α=90° β=90° γ=90°
4-(4-Methoxyphenyl)piperazin-1-ium 3,5-dinitrobenzoate
C11H17N2O,C7H3N2O6
Acta Crystallographica Section E (2020) 76, 4 488-495
a=7.4365(4)Å b=10.6276(6)Å c=13.2700(6)Å
α=92.238(4)° β=97.057(4)° γ=108.618(5)°
4-(4-Methoxyphenyl)piperazin-1-ium 2,4,6-trinitrophenolate
C11H17N2O,C6H2N3O7
Acta Crystallographica Section E (2020) 76, 4 488-495
a=8.7568(6)Å b=6.6292(5)Å c=34.024(2)Å
α=90° β=96.987(6)° γ=90°
4-(4-Methoxyphenyl)piperazin-1-ium 4-aminobenzoate monohydrate
C7H6NO2,C11H17N2O,H2O
Acta Crystallographica Section E (2020) 76, 4 488-495
a=6.2590(7)Å b=7.4549(9)Å c=19.269(2)Å
α=83.280(10)° β=84.7400(10)° γ=85.380(10)°